adthera bio
John Campbell is currently serving as the Chief Scientific Officer at Swarm Oncology and adthera bio. John is also an Executive In Residence at Delin Ventures. With a background in academia, John is a Founder and Advisor at Resolution Therapeutics and holds honorary professor positions at the University of Edinburgh and the University of Glasgow. Prior to this, John held key roles at SNBTS, Miltenyi Biotec, and the University of Glasgow. John holds a PhD in Pathology/Experimental Pathology from The University of Edinburgh and a BSc in Cell and Immunobiology from the University of Aberdeen.
This person is not in any teams
adthera bio
We are a highly experienced digital first company focused exclusively on cell and gene therapy process development and manufacturing. We are the partner of choice in high quality GxP development and manufacturing in Advanced Therapy Medicinal Products. We take your cell therapy ideas and make them into workable medical interventions for patients, all in a regulatory compliant and quality managed system, to get it right first time. Based on brilliant ideas and curious capable minds, we partner with biotechs and academic centres to bring novel ATMP therapies to market and thus to patients who urgently need them. We have highly personalised approaches from the patient to the client to the treatment outcome.